Literature DB >> 31822854

How do different lighting conditions affect the vision and quality of life of people with glaucoma? A systematic review.

Jamie Enoch1, Lee Jones1, Deanna J Taylor1, Carol Bronze2, James F Kirwan3, Pete R Jones1, David P Crabb4.   

Abstract

This article is a systematic review of evidence regarding the impact of different lighting conditions on the vision and quality of life (QoL) of people with primary open-angle glaucoma (POAG). A systematic literature search was carried out using CINAHL, MEDLINE, PsycARTICLES, PsycINFO, Embase, and Ovid Nursing Database for studies: published up to April 2019; including people diagnosed with POAG; and assessing visual function or QoL in response to changing lighting/luminance levels or glare. Two researchers independently screened studies for eligibility. Data were extracted from eligible studies regarding study design, participant characteristics, outcomes, and results. Quality of included studies was critically appraised. Of 8437 studies, 56 eligible studies were included. Studies investigated the effects of lighting on the following domains among people with POAG: QoL (18/56), psychophysical measures (16/56), functional vision (10/56), activities of daily living (10/56), and qualitative findings (2/56). POAG negatively affects low-luminance contrast sensitivity, glare symptoms, and dark adaptation time and extent. In vision-related QoL questionnaires, people with POAG report problems with lighting, glare, and dark adaptation more frequently than any other domain. These problems worsen with progressing visual field loss. Early-stage POAG patients experience significantly more difficulties in low-luminance or changing lighting conditions than age-matched controls (AMCs), challenging perceptions of early-stage POAG as asymptomatic. However, performance-based studies seldom show significant differences between POAG participants and AMCs on tasks simulating daily activities under non-optimal lighting conditions. Further research with larger samples is required to optimise ambient and task-oriented lighting that can support patients' adaptation to POAG.

Entities:  

Mesh:

Year:  2019        PMID: 31822854      PMCID: PMC7002549          DOI: 10.1038/s41433-019-0679-5

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  31 in total

1.  Quality of life in newly diagnosed glaucoma patients : The Collaborative Initial Glaucoma Treatment Study.

Authors:  N K Janz; P A Wren; P R Lichter; D C Musch; B W Gillespie; K E Guire
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

2.  New reduced peptide bond substance P agonists and antagonists: effects on smooth muscle contraction.

Authors:  S Zacharia; W J Rossowski; N Y Jiang; P Hrbas; A Ertan; D H Coy
Journal:  Eur J Pharmacol       Date:  1991-10-22       Impact factor: 4.432

3.  Lifetime visual prognosis of patients with glaucoma.

Authors:  Yi Wei Goh; Ghee Soon Ang; Augusto Azuara-Blanco
Journal:  Clin Exp Ophthalmol       Date:  2011-04-27       Impact factor: 4.207

4.  Visual complaints of patients with glaucoma and controls under optimal and extreme luminance conditions.

Authors:  Ronald A J M Bierings; Frideric L P van Sonderen; Nomdo M Jansonius
Journal:  Acta Ophthalmol       Date:  2018-03-09       Impact factor: 3.761

Review 5.  Glaucoma.

Authors:  Jost B Jonas; Tin Aung; Rupert R Bourne; Alain M Bron; Robert Ritch; Songhomitra Panda-Jonas
Journal:  Lancet       Date:  2017-05-31       Impact factor: 79.321

6.  The association between clinical parameters and glaucoma-specific quality of life in Chinese primary open-angle glaucoma patients.

Authors:  Jacky W Y Lee; Catherine W S Chan; Jonathan C H Chan; Q Li; Jimmy S M Lai
Journal:  Hong Kong Med J       Date:  2014-02-28       Impact factor: 2.227

7.  A view on glaucoma--are we seeing it clearly?

Authors:  D P Crabb
Journal:  Eye (Lond)       Date:  2015-11-27       Impact factor: 3.775

8.  Validation of the Glaucoma Quality of Life-15 Questionnaire in Serbian language.

Authors:  Ivan Sencanic; Tatjana Gazibara; Jelena Dotlic; Miroslav Stamenkovic; Vesna Jaksic; Marija Bozic; Anita Grgurevic
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

9.  The impact of primary open-angle glaucoma: Comparison of vision-specific (National Eye Institute Visual Function Questionnaire-25) and disease-specific (Glaucoma Quality of Life-15 and Viswanathan 10) patient-reported outcome (PRO) instruments.

Authors:  Suresh Kumar; Sahil Thakur; Parul Ichhpujani
Journal:  Indian J Ophthalmol       Date:  2019-01       Impact factor: 1.848

10.  A comparison of the NEIVFQ25 and GQL-15 questionnaires in Nigerian glaucoma patients.

Authors:  Chigozie A Mbadugha; Adeola O Onakoya; Olufisayo T Aribaba; Folashade B Akinsola
Journal:  Clin Ophthalmol       Date:  2012-09-03
View more
  4 in total

1.  Seeing other perspectives: evaluating the use of virtual and augmented reality to simulate visual impairments (OpenVisSim).

Authors:  Pete R Jones; Tamás Somoskeöy; Hugo Chow-Wing-Bom; David P Crabb
Journal:  NPJ Digit Med       Date:  2020-03-10

2.  Concept Mapping to Identify Content for a Performance-Based Measure of Low Luminance Vision-Related Activities of Daily Living.

Authors:  Sharon A Bentley; Alex A Black; Gregory P Hindmarsh; Cynthia Owsley; Joanne M Wood
Journal:  Transl Vis Sci Technol       Date:  2022-09-01       Impact factor: 3.048

3.  Seeing other perspectives: evaluating the use of virtual and augmented reality to simulate visual impairments (OpenVisSim).

Authors:  Pete R Jones; Tamás Somoskeöy; Hugo Chow-Wing-Bom; David P Crabb
Journal:  NPJ Digit Med       Date:  2020-03-10

4.  Assessing Functional Disability in Glaucoma: The Relative Importance of Central Versus Far Peripheral Visual Fields.

Authors:  Jamie L Odden; Aleksandra Mihailovic; Michael V Boland; David S Friedman; Sheila K West; Pradeep Y Ramulu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.